• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC. (CS-WOODRIDGE) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-19A
Device Problems Calcified (1077); Degraded (1153); Occlusion Within Device (1423); Reflux within Device (1522)
Patient Problems Aortic Insufficiency (1715); Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Calcium Deposits/Calcification (1758); High Blood Pressure/ Hypertension (1908); Pulmonary Edema (2020)
Event Date 03/17/2015
Event Type  Injury  
Event Description
On (b)(6) 2011, a 19mm trifecta valve was implanted due to aortic valve stenosis and insufficiency.A trans-esophageal echo on (b)(6) 2015 revealed grade ii aortic insufficiency.The patient presented with hypertensive and pulmonary edema requiring hospitalization from (b)(6) 2015.A diagnostic x-ray showed acute pulmonary edema with central and peripheral lung stasis.Medical management included oxygen and furosemide.The patient was stabilized.On (b)(6) 2015, the patient was diagnosed with severe aortic valve stenosis and regurgitation due to structural valve deterioration caused by calcification.The valve was explanted on (b)(6) 2015 and a 19mm non-sjm valve was implanted.At explant, the trifecta valve was noted to be heavily calcified in the commissural region and difficult to excise due to the small annulus.The patient was released (b)(6) 2015.
 
Manufacturer Narrative
(b)(4).The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The results of the investigation are inconclusive since the device was not returned for analysis.Our investigation was limited to the review of the device history record, which showed that each manufacturing and inspection operation was performed and indicated complete in accordance with sjm specifications and procedures.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer (Section G)
ST. JUDE MEDICAL, INC. (CS-WOODRIDGE)
177 east county road b
st. paul MN 55117
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517564470
MDR Report Key4755863
MDR Text Key21058310
Report Number3007113487-2015-00022
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 04/15/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/07/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/24/2013
Device Model NumberTF-19A
Device Catalogue NumberTF-19A
Device Lot Number3312415
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/15/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/26/2011
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-